217 related articles for article (PubMed ID: 12837515)
1. Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia.
Arvindakshan M; Ghate M; Ranjekar PK; Evans DR; Mahadik SP
Schizophr Res; 2003 Aug; 62(3):195-204. PubMed ID: 12837515
[TBL] [Abstract][Full Text] [Related]
2. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics.
Khan MM; Evans DR; Gunna V; Scheffer RE; Parikh VV; Mahadik SP
Schizophr Res; 2002 Nov; 58(1):1-10. PubMed ID: 12363384
[TBL] [Abstract][Full Text] [Related]
3. The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study.
Sivrioglu EY; Kirli S; Sipahioglu D; Gursoy B; Sarandöl E
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1493-9. PubMed ID: 17688987
[TBL] [Abstract][Full Text] [Related]
4. Vitamin E and essential polyunsaturated fatty acids supplementation in schizophrenia patients treated with haloperidol.
Bošković M; Vovk T; Koprivšek J; Plesničar BK; Grabnar I
Nutr Neurosci; 2016 May; 19(4):156-61. PubMed ID: 25056532
[TBL] [Abstract][Full Text] [Related]
5. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients.
Arvindakshan M; Sitasawad S; Debsikdar V; Ghate M; Evans D; Horrobin DF; Bennett C; Ranjekar PK; Mahadik SP
Biol Psychiatry; 2003 Jan; 53(1):56-64. PubMed ID: 12513945
[TBL] [Abstract][Full Text] [Related]
6. A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia.
Bentsen H; Osnes K; Refsum H; Solberg DK; Bøhmer T
Transl Psychiatry; 2013 Dec; 3(12):e335. PubMed ID: 24346133
[TBL] [Abstract][Full Text] [Related]
7. Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects.
Remans PH; Sont JK; Wagenaar LW; Wouters-Wesseling W; Zuijderduin WM; Jongma A; Breedveld FC; Van Laar JM
Eur J Clin Nutr; 2004 Jun; 58(6):839-45. PubMed ID: 15164103
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia.
Mahadik SP; Evans D; Lal H
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):463-93. PubMed ID: 11370992
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment.
Evans DR; Parikh VV; Khan MM; Coussons C; Buckley PF; Mahadik SP
Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):393-9. PubMed ID: 14623492
[TBL] [Abstract][Full Text] [Related]
10. Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants.
Brude IR; Drevon CA; Hjermann I; Seljeflot I; Lund-Katz S; Saarem K; Sandstad B; Solvoll K; Halvorsen B; Arnesen H; Nenseter MS
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2576-88. PubMed ID: 9409230
[TBL] [Abstract][Full Text] [Related]
11. Polyunsaturated fatty acid supplementation for schizophrenia.
Joy CB; Mumby-Croft R; Joy LA
Cochrane Database Syst Rev; 2003; (2):CD001257. PubMed ID: 12804400
[TBL] [Abstract][Full Text] [Related]
12. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients.
Ranjekar PK; Hinge A; Hegde MV; Ghate M; Kale A; Sitasawad S; Wagh UV; Debsikdar VB; Mahadik SP
Psychiatry Res; 2003 Dec; 121(2):109-22. PubMed ID: 14656446
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methods.
Pawełczyk T; Grancow M; Kotlicka-Antczak M; Trafalska E; Gębski P; Szemraj J; Żurner N; Pawełczyk A
BMC Psychiatry; 2015 May; 15():97. PubMed ID: 25934131
[TBL] [Abstract][Full Text] [Related]
14. Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements.
Carney RM; Steinmeyer BC; Freedland KE; Rubin EH; Rich MW; Harris WS
J Clin Psychiatry; 2016 Feb; 77(2):e138-43. PubMed ID: 26930527
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms.
Hsu MC; Huang YS; Ouyang WC
Lipids Health Dis; 2020 Jul; 19(1):159. PubMed ID: 32620164
[TBL] [Abstract][Full Text] [Related]
16. Vitamin E and C supplementation prevents decrease of eicosapentaenoic acid in mononuclear cells in chronic hepatitis C patients during combination therapy of interferon alpha-2b and ribavirin.
Murakami Y; Nagai A; Kawakami T; Hino K; Kitase A; Hara Y; Okuda M; Okita K; Okita M
Nutrition; 2006 Feb; 22(2):114-22. PubMed ID: 16459223
[TBL] [Abstract][Full Text] [Related]
17. Relationship of omega-3 and omega-6 fatty acids with semen characteristics, and anti-oxidant status of seminal plasma: a comparison between fertile and infertile men.
Safarinejad MR; Hosseini SY; Dadkhah F; Asgari MA
Clin Nutr; 2010 Feb; 29(1):100-5. PubMed ID: 19666200
[TBL] [Abstract][Full Text] [Related]
18. Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Bone Turnover in Older Women.
Dong H; Hutchins-Wiese H; Kleppinger A; Annis K; Liva E; Lammi-Keefe C; Durham H; Feinn R; Kenny AM
Int J Vitam Nutr Res; 2014; 84(3-4):124-32. PubMed ID: 26098476
[TBL] [Abstract][Full Text] [Related]
19. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
20. Opposite changes in predominantly docosahexaenoic acid (DHA) in cerebrospinal fluid and red blood cells from never-medicated first-episode psychotic patients.
Kale A; Joshi S; Naphade N; Sapkale S; Raju MS; Pillai A; Nasrallah H; Mahadik SP
Schizophr Res; 2008 Jan; 98(1-3):295-301. PubMed ID: 17997280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
